Zoetis (ZTS) Construction in Progress (2012 - 2025)
Zoetis (ZTS) reported Construction in Progress of $1.3 billion for Q4 2025, down 4.29% year-over-year from $1.4 billion in Q4 2024, and down 4.29% quarter-over-quarter from $1.4 billion in Q4 2024.
Zoetis (ZTS) Construction in Progress (2012 - 2025) Analysis & Trends
Zoetis (ZTS) has 14 years of Construction in Progress data on file, last reported at $1.3 billion in Q4 2025.
- Construction in Progress for Q4 2025 came in at $1.3 billion, down 4.29% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.3 billion (down 4.29% YoY), and the FY2025 annual result was $1.3 billion, down 4.29% from the prior year.
- Construction in Progress declined to $1.3 billion in Q4 2025 per ZTS's latest filing, from $1.4 billion in the prior quarter.
- Over five years, Construction in Progress peaked at $1.4 billion in Q4 2024 and troughed at $742.0 million in Q4 2021.
- A 5-year average of $1.1 billion and a median of $1.1 billion in 2023 frame the typical range for Construction in Progress.
- The sharpest annual moves came in 2023 and 2025: Construction in Progress jumped 33.29% in 2023, then fell 4.29% in 2025.
- A 5-year view of Construction in Progress shows it stood at $742.0 million in 2021, then gained by 9.7% to $814.0 million in 2022, then jumped by 33.29% to $1.1 billion in 2023, then climbed by 24.7% to $1.4 billion in 2024, then decreased by 4.29% to $1.3 billion in 2025.
- Business Quant data shows ZTS's Construction in Progress at $1.3 billion in Q4 2025, $1.4 billion in Q4 2024, and $1.1 billion in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.30 Bn |
| Dec 31, 2024 | 1.35 Bn |
| Dec 31, 2023 | 1.09 Bn |
| Dec 31, 2022 | 814.00 Mn |
| Dec 31, 2021 | 742.00 Mn |
| Dec 31, 2020 | 673.00 Mn |
| Dec 31, 2019 | 553.00 Mn |
| Dec 31, 2018 | 454.00 Mn |
| Dec 31, 2017 | 254.00 Mn |
| Dec 31, 2016 | 212.00 Mn |
| Dec 31, 2015 | 185.00 Mn |
| Dec 31, 2014 | 167.00 Mn |
| Dec 31, 2013 | 199.00 Mn |
| Dec 31, 2012 | 159.00 Mn |